382 related articles for article (PubMed ID: 11377540)
1. Tolerability of mycophenolate mofetil in organ transplant recipients.
Schweizer RT; Meisterling LD
Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
[No Abstract] [Full Text] [Related]
2. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
Taheri M; Pourmand G; Mehrsai AR; Mansoori D
Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity.
Torras J; Figueras J; Lama C; Fabregat J; Ramos E; Rafecas A; Gil-Vernet S; Pares D; Busquets J; Jaurrieta E
Transplant Proc; 1999 Sep; 31(6):2430. PubMed ID: 10500656
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
Tsang WK; Tong KL; Yeung S; Lee W; Chan HW
Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921
[No Abstract] [Full Text] [Related]
5. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
[No Abstract] [Full Text] [Related]
6. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA
Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
Vanrenterghem Y; Squifflet JP; Forsythe J; Heeman U; Bäckman L; Taube D; Morales JM; Ekberg H; van Hooff J; Zanker B; Dietl KH; Talbot D; Hauser I; Tydén G; Claesson K; Mühlbacher F
Transplant Proc; 1998 Jun; 30(4):1290-1. PubMed ID: 9636523
[No Abstract] [Full Text] [Related]
8. Triple therapy with mycophenolate mofetil versus azathioprine.
Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
[No Abstract] [Full Text] [Related]
9. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
[No Abstract] [Full Text] [Related]
10. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
[No Abstract] [Full Text] [Related]
11. How to handle mycophenolate mofetil in combination with tacrolimus?
Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
[No Abstract] [Full Text] [Related]
12. A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus.
Daoud AJ; Schroeder TJ; Shah M; Hariharan S; Peddi VR; Weiskittel P; First MR
Transplant Proc; 1998 Dec; 30(8):4079-81. PubMed ID: 9865303
[No Abstract] [Full Text] [Related]
13. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR
Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439
[No Abstract] [Full Text] [Related]
14. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027
[No Abstract] [Full Text] [Related]
15. Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial.
Yang HC; Holman MJ; Langhoff E; Ulsh PJ; Dellock CA; Gupta M; Ahsan N
Transplant Proc; 1999; 31(1-2):1121-4. PubMed ID: 10083501
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
Suhail SM; Vathsala A; Lou HX; Woo KT
Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922
[No Abstract] [Full Text] [Related]
17. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
[No Abstract] [Full Text] [Related]
18. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
Weber M; Deng S; Arenas J; Aradhye S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
Transplant Proc; 1997 Dec; 29(8):3669-70. PubMed ID: 9414883
[No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
Fabrega AJ; Corwin CL; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
[No Abstract] [Full Text] [Related]
20. Clinical study of FK 506 in renal transplant recipients.
Youhua Z; Zhinlian M; Liming W
Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
